| Literature DB >> 35887433 |
Alex Moskaluk1, Lauren Darlington1, Sally Kuhn2, Elisa Behzadi1, Roderick B Gagne3, Christopher P Kozakiewicz1, Sue VandeWoude1.
Abstract
Microsporum canis is the primary agent causing dermatophytosis in cats, and also infects humans, dogs, and other species. Assessment of genetic variation among M. canis isolates in the United States has not been conducted. Further, M. canis mating type and assessment of disease severity associated with genotypic characteristics have not been rigorously evaluated. We therefore isolated M. canis from 191 domestic cats across the US and characterized genotypes by evaluation of ITS sequence, MAT locus, and microsatellite loci analysis. The genes SSU1 and SUB3, which are associated with keratin adhesion and digestion, were sequenced from a subset of isolates to evaluate potential genetic associations with virulence. Analysis of microsatellite makers revealed three M. canis genetic clusters. Both clinic location and disease severity were significant predictors of microsatellite variants. 100% of the M. canis isolates were MAT1-1 mating gene type, indicating that MAT1-2 is very rare or extinct in the US and that asexual reproduction is the dominant form of replication. No genetic variation at SSU1 and SUB3 was observed. These findings pave the way for novel testing modalities for M. canis and provide insights about transmission and ecology of this ubiquitous and relatively uncharacterized agent.Entities:
Keywords: Microsporum canis; cats; dermatophytosis; mating-type; multilocus microsatellite typing
Year: 2022 PMID: 35887433 PMCID: PMC9321804 DOI: 10.3390/jof8070676
Source DB: PubMed Journal: J Fungi (Basel) ISSN: 2309-608X
Primer sequences with corresponding fluorescent dyes (6-FAM, VIC, NED, and PET) used for the microsatellite loci.
| Panel | Microsatellite Locus | Orientation | Primer Sequence 5′ to 3′ | Reference |
|---|---|---|---|---|
| 1 | 1 | Forward | [VIC]GAAGGAGGTATATATGGGTGTG | [ |
| Reverse | GATAAGGTGTTTGGCACTGA | |||
| 4 | Forward | [6-FAM]CAGCATCTAAATAACTGGCCTA | [ | |
| Reverse | TTTTCTTTCTACTTCCCGTTG | |||
| 5 | Forward | [NED]GGTTTACACGCAGCATGA | [ | |
| Reverse | CGTGGCTGAAGAAGTCTACC | |||
| 8 | Forward | [PET]GATCGGAGCATGCCATACAG | [ | |
| Reverse | TCTTCCCACCCTTCTCAATG | |||
| 2 | 2 | Forward | [NED]GGGAACAATCTGCCTTAAAC | [ |
| Reverse | CACAGAGATATGCCGTATGC | |||
| 3 | Forward | [PET]AGGTGTTTGGCACTGAGC | [ | |
| Reverse | CGAAGAGAAGGAGGTATATATGG | |||
| 6 | Forward | [6-FAM]CGTCTGGGACTTGGTAGTAA | [ | |
| Reverse | TCGGAGGATCTTTAAACTGT | |||
| 7 | Forward | [VIC]GCCAAAGAGCTTGCTGAG | [ | |
| Reverse | CGTTAGCATGCATCTCTCTATAC |
One hundred forty-seven samples were included in microsatellite analysis associated with reported clinical attributes.
| Sample Categories | CA | NM | BC | LC | WC | MA | NJ | Total |
|---|---|---|---|---|---|---|---|---|
| Samples received | 165 | 53 | 8 | 14 | 8 | 8 | 2 |
|
| Culture positive samples | 132 | 42 | 6 | 4 | 6 | 5 | 1 |
|
| Samples with clinical data | 139 | 36 | 8 | 14 | 0 | 7 | 2 * |
|
| Culture + clinical data | 109 | 31 | 6 | 4 | 0 | 4 | 1 * |
|
| Microsatellite samples | 122 | 36 | 6 | 4 | 6 | 5 | 1 |
|
| Microsatellite + clinical data | 106 | 26 | 6 | 4 | 0 | 4 | 1 * |
|
* clinical data from New Jersey samples were excluded from downstream analysis due to the patients being treated from dermatophytosis prior to sample collection. Culture + clinical data samples are samples that were culture positive for Microsporum canis and had corresponding clinical data for the patient. Microsatellite + clinical data samples are samples that were successfully sequenced for the microsatellite regions and had corresponding clinical data for the patient. CA = California; NM = New Mexico; BC = Boulder County, CO; LC = Larimer County, CO; WC = Weld County, CO; MA = Massachusetts; NJ = New Jersey.
Summary of clinical presentation data for Microsporum canis positive cats.
| Clinical Parameters | Total ( |
|---|---|
| Sample from shelter or private practice | Shelter (150, 97.4%) |
| Private practice (4, 2.6%) | |
| Age | Kitten (149, 96.8%) |
| Sex | Female (74, 48.1%) |
| Neuter status | Intact (138, 89.6%) |
| Breed | DSH (137, 89%) |
| DMH (11, 7.1%) | |
| DLH (4, 2.6%) | |
| Persian (1, 0.6%) | |
| Exotic Shorthair (1, 0.6%) | |
|
| |
| Stray | 1 (138, 89.6%) |
| Single cat—owned household | 2 (0, 0%) |
| Multi cat—owned household | 3 (3, 1.9%) |
| Previously owned—other animals unknown | 4 (2, 1.3%) |
| Transferred from shelter | 5 (11, 7.1%) |
|
| |
| Shelter/rescue—single cat kennel | 1 (40, 26%) |
| Shelter/rescue—multiple cat kennel | 2 (109, 70.8%) |
| Client owned—single cat household | 3 (1, 0.6%) |
| Client owned—multiple cay household | 4 (4, 2.6%) |
|
| |
| Yes—topical parasite preventatives or dewormer | 1 (32, 20.8%) |
| Yes—oral parasite preventatives or dewormer | 2 (57, 37%) |
| Yes—other | 3 (2, 1.3%) |
| No | 4 (83, 53.9%) |
| Concurrent medical conditions * | URI (28, 18.2%) |
| Ectoparasites (5, 3.2%) | |
| Superficial pyoderma (1, 0.6%) | |
| IBD (1, 0.6%) | |
| Diarrhea (1, 0.6%) | |
| Otitis media (1, 0.6%) | |
| Degloved chin (1, 0.6%) | |
| Underweight (1, 0.6%) | |
| None (114, 74%) | |
|
| |
| Wood’s lamp | 1 (151, 98.1%) |
| Fungal culture | 2 (10, 6.5%) |
| IDEXX PCR | 3 (4, 2.6%) |
| Hair observed under microscope | 4 (2, 1.3%) |
| Other | 5 (3, 1.9%) |
| None | 6 (1, 0.6%) |
| If diagnostics have been performed, what were the results? | Wood’s lamp positive (132, 87.4%) |
|
| |
| 1 | 1 (29, 18.8%) |
| 2–5 | 2 (67, 43.5%) |
| 5+ | 3 (46, 29.9%) |
| None—no lesions present | 4 (12, 7.8%) |
|
| |
| Less than 0.5 inch (smaller than a dime) | 1 (62, 40.2%) |
| Between 0.5 inch and 1 inch (size of a penny) | 2 (59, 38.3%) |
| Greater than 1 inch (larger than a penny) | 3 (21, 13.6%) |
| N/A—no lesions present | 4 (12, 7.8%) |
|
| |
| Head | 1 (124, 80.5%) |
| Neck | 2 (46, 30%) |
| Abdomen | 3 (46, 30%) |
| Back | 4 (31, 20.1%) |
| Tail including base of tail | 5 (28, 18.2%) |
| Legs including paws | 6 (77, 50%) |
| N/A—no lesions present | 7 (12, 7.8%) |
|
| |
| Alopecia | 1 (137, 89%) |
| Scales/crusts | 2 (95, 61.7%) |
| Reddened/erythematous | 3 (9, 5.8%) |
| Papules/pustules | 4 (0, 0%) |
| Miliary dermatitis | 5 (2, 1.3%) |
| N/A—no lesions present | 6 (12, 7.8%) |
|
| |
| Mild—lesions are small and confined to focal area | 1 (49, 31.8%) |
| Mild to moderate | 2 (20, 13%) |
| Moderate—lesions are found in multiple areas, but is not widespread | 3 (39, 25.3%) |
| Moderate to severe | 4 (14, 9.1%) |
| Severe—lesions are large and found all over the body | 5 (20, 13%) |
| N/A—no lesions present | 6 (12, 7.8%) |
* = Percentages are greater than 100 as patients can have more than one answer. DSH = domestic shorthair, DMH = domestic medium hair, DLH = domestic long hair, N/A = not applicable, URI = upper respiratory infection, IBD = inflammatory bowel disease.
Figure 1Representative images of microsatellite genotypes. MS4 peaks of unrelated isolates (CBS 113480, BC3, CA107, MA3) showing varying allele sizes at 107 bp, 159 bp, 127 bp, and 121 bp, respectively. CBS = Westerdijk Fungal Biodiversity Centre; BC = Boulder County, CO; CA = California; MA = Massachusetts.
Figure 2Microsatellite locus allelic diversity varies among Microsporum canis isolates. Allele sizes for microsatellite loci (MS) 1–8 for each sample are plotted with Boulder County, CO (n = 6); California (n = 122); Larimer County, CO (n = 4); Massachusetts (n = 5); New Jersey (n = 1); New Mexico (n = 36); Weld County, CO (n = 9). The microsatellite loci had the following ranges: 105–117 bp (MS1), 95–101 bp (MS2), 110–116 bp (MS3), 103–161 bp (MS4), 96–106 bp (MS5), 105–115 bp (MS6), 121–127 bp (MS7), and 112–118 bp (MS8).
Eight microsatellite loci demonstrate different degrees of polymorphism across samples tested.
| Microsatellite Locus | Allele Size Range | Most Common Allele (% of Alleles) | % of Missing Genotypes |
|---|---|---|---|
| 1 | 105–117 bp | 115 bp (72%) | 7.2% |
| 2 | 95–101 bp | 97 bp (78%) | 0% |
| 3 | 110–116 bp | 114 bp (79%) | 13% |
| 4 | 103–161 bp | 155 bp (43%) | 1.7% |
| 5 | 96–106 bp | 102 bp (47%) | 0% |
| 6 | 105–115 bp | 109 bp (48%) | 21% |
| 7 | 121–127 bp | 125 bp (81%) | 2.2% |
| 8 | 112–118 bp | 116 bp (79%) | 2.2% |
Figure 3Disease severity and location associated with microsatellite genotype. Distance-based redundancy analysis showed significant association between disease severity and microsatellite variation. (A)—samples colored based on clinic location. (B)—samples colored by disease severity. Locations included in study are California (CA); New Mexico (NM); Boulder County, CO (BC); Larimer County, CO (LC); and Massachusetts (MA). Position on the plot for each sample depicts genetic differentiation. Arrow = disease severity increases direction of arrow.
Figure 4Evidence of separation based on clinic location for Boulder, Massachusetts, and part of California. Principal component analysis (PCA) plot for microsatellite regions, with samples colored according to clinic. One sample from Massachusetts was an outlier. The portion of California samples that appear distinct were collected in the same month. Locations included in study are California; New Mexico; Boulder County, CO; Larimer County, CO; Weld County, CO; New Jersey; and Massachusetts.
Figure 5Samples from Boulder County, CO and a portion of California clustered apart from other sampled locations. Structure plots with K values 3–5. The amount of vertical color for each sample corresponds with the percentage of belonging to that color cluster. Admixture increased for plots using K = 4 and K = 5. Locations included in study were Boulder County, CO (1); California (2); Larimer County, CO (3); Massachusetts (4); New Jersey (5); New Mexico (6); and Weld County, CO (7).